Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    JKY_VH
    wrote on sidst redigeret af
    #129

    Ja Scvej, det har han i hvert fald tidligere sagt at han vil "Mellemmændene, de såkaldte PBM’er, skal ud af ligningen, lyder det fra USA’s kommende præsident."

    1 Reply Last reply
    0
    • B Offline
      B Offline
      Bjæssing09
      wrote on sidst redigeret af
      #130

      Man skal sidde på hænderne her og supplere, hvis man har lidt på kistebunden. Novo skal nok rejse sig igen........

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Stockwatch1
        wrote on sidst redigeret af
        #131

        UBS:
        Discontinuations in STEP UP were lower than in STEP 1 according to our conversations
        with the company, which indicates that tolerability was reasonable. The study allowed
        for some flexibility in dosing, but not to the extent of the REDEFINE dosing regimens (the
        company state the STEP UP is more similar to the original STEP dosing regimens than vs
        REDEFINE)

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Stockwatch1
          wrote on sidst redigeret af
          #132

          In terms of % of patients that finished on the top dose, Novo state that it
          was lower for 7.2mg vs 2.4mg but have not provided numbers

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Stockwatch1
            wrote on sidst redigeret af
            #133

            Pushback from the results is that this step up in efficacy for sema reduces the need for
            CagriSema and does not extend the semaglutide patent cliff. We still see CagriSema as
            another step ahead of efficacy, with REDEFINE-1 providing 2% additional weight loss
            despite the more flexible dosing regimens and could provide further differentiation in
            type-2 diabetics and comorbidities.

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Stockwatch1
              wrote on sidst redigeret af
              #134

              We
              see the results as providing a boost for the longer term Wegovy franchise, albeit does
              not extend patent life. We expect any decision on filing and launch to take account of
              the supply situation, but we would expect any regulatory review to be only c.6 months
              given it is a supplemental dosage and not a new indication.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Stockwatch1
                wrote on sidst redigeret af
                #135

                UBS' kommentarer til dagens data, netop udsendt

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #136

                  tak Sw

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    koden
                    wrote on sidst redigeret af
                    #137

                    Da de mest pessimistiske analytikere satte kursmål 5xx tilbage i sommers, da tænkte jeg de havde fis i kasketten. Men må sige de fik ret.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #138

                      Novo er ramt af usikkerhed vurderer Sydbank: Prisforhandlinger bør ikke overraske https://proinvestor.com/investornyt/1266560/novo-er-ramt-af-usikkerhed-vurderer-sydbank-prisforhandlinger-bor-ikke-overraske

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #139

                        Video - Novo Nordisk aktieanalyse! Købsmulighed? https://proinvestor.com/boards/124284

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          Hansen
                          wrote on sidst redigeret af
                          #140

                          Fra bioSpace https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial?_gl=1*1t5e3kc*_up*MQ.._gaMTQ4OTIxMjQ1Ni4xNzM3MjcwOTI2*_ga_Q90M6MWJZ4*MTczNzI3MDkyNC4xLjAuMTczNzI3MTExNi4wLjAuMA..

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #141

                            Novo Nordisk: Det halvfyldte glas er blevet halvt tomt https://proinvestor.com/boards/124293

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #142

                              Nordea gentager køb og kursmål 977 We reiterate Buy with an unchanged DCF-derived target of DKK 977 per share

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #143

                                Novo Nordisks fald i dag, det er virkelig vildt at være vidne til ...

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  koden
                                  wrote on sidst redigeret af
                                  #144

                                  LLY er også nede i dag. Men ja vildt og helt i skoven.

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Riis7
                                    wrote on sidst redigeret af
                                    #145

                                    usa er lukket , MLK dag i usa
                                    , LLY er fra i fredags

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #146

                                      Ja US lukket og kursen på Novo? Jeg er målløs over at det kan fortsætte på den måde.

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #147

                                        Fra debatten: Trumps tale ud fra et Novo-synspunkt https://proinvestor.com/boards/124311

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          koden
                                          wrote on sidst redigeret af
                                          #148

                                          nå ja sorry 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper